Literature DB >> 2732344

Association of oral candidiasis with diabetic control.

L V Hill1, M H Tan, L H Pereira, J A Embil.   

Abstract

Factors associated with oral candidiasis in 51 diabetics were examined. The prevalence of oral yeast infection was 49 (n = 25)%. The association with diabetic control, as measured by fasting blood glucose concentration, urinary glucose concentration, and glycosylated haemoglobin, with the presence of yeast was analysed in the 51 diabetic patients. Glycosylated haemoglobin above 12% was strongly associated with oral yeast infection (odds ratio = 13.00) (p less than 0.001), while fasting blood and urinary glucose concentrations were not. The risk of oral candidiasis among diabetics wearing dentures was significantly higher than among dentate diabetics (odds ratio = 4.78). After controlling for the effect of denture wearing, glycosylated haemoglobin greater than 12% remained highly predictive of oral yeast infection, particularly among diabetics without dentures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732344      PMCID: PMC1141957          DOI: 10.1136/jcp.42.5.502

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Observations on the carriage of Candida albicans in man.

Authors:  A J Barlow; F W Chattaway
Journal:  Br J Dermatol       Date:  1969-02       Impact factor: 9.302

2.  Vulvovaginal candidiasis--what we do and do not know.

Authors:  J D Sobel
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

3.  The microbial flora of the vagina and its relationship to bacteriuria in diabetic and non-diabetic women.

Authors:  D N Williams; A H Knight; H King; D M Harris
Journal:  Br J Urol       Date:  1975-08

4.  The prevalence of Candida albicans in the mouths of tobacco smokers with and without oral mucous membrane keratoses.

Authors:  R J Bastiaan; P C Reade
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1982-02

5.  The prevalence and intra-oral distribution of Candida albicans in man.

Authors:  T M Arendorf; D M Walker
Journal:  Arch Oral Biol       Date:  1980       Impact factor: 2.633

6.  Pathogenic carrier rate in diabetes mellitus.

Authors:  P T Chandler; S D Chandler
Journal:  Am J Med Sci       Date:  1977 May-Jun       Impact factor: 2.378

7.  The relationship of pregnancy, vaginal candidiasis and glucose metabolism.

Authors:  S C Robinson; W C Nicholas; D T Lee; J M Wanklin; B Zwicker
Journal:  Can Med Assoc J       Date:  1967-03-11       Impact factor: 8.262

8.  Clotrimazole (Canesten) in the treatment of candidal balanitis in men. With incidental observations on diabetic candidal balanoposthitis.

Authors:  M A Waugh; E G Evans; K C Nayyar; R Fong
Journal:  Br J Vener Dis       Date:  1978-06

9.  Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients.

Authors:  F C Odds; E G Evans; M A Taylor; J K Wales
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

10.  Candidal infections and populations of Candida albicans in mouths of diabetics.

Authors:  L M Tapper-Jones; M J Aldred; D M Walker; T M Hayes
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411

View more
  16 in total

1.  Buccal alterations in diabetes mellitus.

Authors:  Carlos Antonio Negrato; Olinda Tarzia
Journal:  Diabetol Metab Syndr       Date:  2010-01-15       Impact factor: 3.320

2.  Local, systemic, demographic, and health-related factors influencing pathogenic yeast spectrum and antifungal drug administration frequency in oral candidiasis: a retrospective study.

Authors:  Moritz Hertel; Andrea Maria Schmidt-Westhausen; Frank-Peter Strietzel
Journal:  Clin Oral Investig       Date:  2015-10-19       Impact factor: 3.573

3.  Oral Manifestations and Complications of Diabetes Mellitus: A review.

Authors:  Awatif Y Al-Maskari; Masoud Y Al-Maskari; Salem Al-Sudairy
Journal:  Sultan Qaboos Univ Med J       Date:  2011-05-15

4.  Clinical questionnaire study of oral health care and symptoms in diabetic vs. non-diabetic predialysis chronic kidney disease patients.

Authors:  Maarit Vesterinen; Hellevi Ruokonen; Jussi Furuholm; Eero Honkanen; Jukka H Meurman
Journal:  Clin Oral Investig       Date:  2011-04-01       Impact factor: 3.573

5.  Oral health in predialysis patients with emphasis on diabetic nephropathy.

Authors:  Maarit Vesterinen; Hellevi Ruokonen; Jussi Furuholm; Eero Honkanen; Jukka H Meurman
Journal:  Clin Oral Investig       Date:  2010-01-19       Impact factor: 3.573

6.  The role of aldose reductase inhibition in diabetic neutrophil phagocytosis and killing.

Authors:  S E Tebbs; A M Gonzalez; R M Wilson
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

7.  Factors influencing oral carriage of yeasts among individuals with diabetes mellitus.

Authors:  F Z Aly; C C Blackwell; D A Mackenzie; D M Weir; B F Clarke
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

8.  Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls.

Authors:  Richard J Jurevic; Mai Bai; Robert B Chadwick; Theodore C White; Beverly A Dale
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Prevalence of Candida albicans in primary endodontic infections associated with a higher frequency of apical periodontitis in type two diabetes mellitus patients.

Authors:  Rocio De la Torre-Luna; Rubén Abraham Domínguez-Pérez; Ana Laura Guillén-Nepita; José Luis Ayala-Herrera; Rita Elizabeth Martínez-Martínez; Ma Esther Romero-Ayala; Rosa Martha Pérez-Serrano; Ma Soledad Vázquez-Garcidueñas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-16       Impact factor: 3.267

10.  Relationship of tooth mortality and implant treatment in Type 2 diabetes mellitus patients in Korean adults.

Authors:  Hyun-Yub Jung; Yong-Gun Kim; Myoung-Uk Jin; Jin-Hyun Cho; Jae-Mok Lee
Journal:  J Adv Prosthodont       Date:  2013-02-28       Impact factor: 1.904

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.